Jyong Biotech Ltd. Ordinary Shares
MENS | NASDAQ
$1.86
-$0.02 (-1.06%)
Nov 2, 2026, 12:12 PM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.18M | 1.18M | 135K | 98K | 98K | 96K | 96K | 177K |
Short-Term Investments | n/a | n/a | 16.88M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 15M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6K | 2.08M | 7K | 2.97M | 2.97M | 2.9M | 2.9M | 2.87M |
Receivables | 13.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 854K | 13.51M | 153K | 108K | 3K | 104K | 3K | 1.66M |
Total Current Assets | 15.54M | 15.54M | 17.16M | 206K | 206K | 200K | 200K | 1.84M |
Property-Plant & Equipment | 5.23M | 3.15M | 5.5M | 3.19M | 3.19M | 3.34M | 3.34M | 3.54M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.24M | 5.24M | 20.51M | 6.16M | 6.16M | 6.24M | 6.24M | 6.41M |
Total Assets | 20.78M | 20.78M | 37.67M | 6.37M | 6.37M | 6.44M | 6.44M | 8.25M |
Account Payables | 2K | 2K | 3K | 3K | 3K | 9K | 9K | 2K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 8.36M | 8.28M | 22.92M | 7.28M | 7.28M | 7.46M | 7.46M | 7.97M |
Other Current Liabilities | 26.31M | 3.55M | 4.64M | 3.33M | 3.37M | 3.31M | 3.33M | 4.99M |
Total Current Liabilities | 34.81M | 34.81M | 27.55M | 12.13M | 12.13M | 11.93M | 11.93M | 14.26M |
Long-Term Debt | 10.16M | 10.16M | 12.27M | 10.68M | 10.68M | 9.67M | 9.67M | 8.52M |
Other Long-Term Liabilities | 688K | 688K | 20.31M | 20.06M | 20.06M | 19.69M | 19.69M | 19.47M |
Total Long-Term Liabilities | 10.87M | 10.87M | 32.59M | 30.76M | 30.76M | 29.43M | 29.43M | 28.06M |
Total Liabilities | 45.68M | 45.68M | 60.14M | 42.89M | 42.89M | 41.37M | 41.37M | 42.32M |
Total Debt | 18.55M | 18.55M | 35.19M | 18.14M | 18.14M | 17.37M | 17.37M | 16.69M |
Book Value | -24.91M | -24.91M | -22.47M | -36.52M | -36.52M | -34.93M | -34.93M | -34.07M |
Book Value Per Share | -0.34 | -335.37 | -0.31 | -510.28 | -510.28 | -488.02 | -488.02 | -476.10 |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -37.75M | -37.75M | -34.33M | -33.08M | -33.08M | -31.39M | -31.39M | -30.06M |
Comprehensive Income | 682K | 682K | -38K | 1.12M | 1.12M | 1.02M | 1.02M | 548K |
Shareholders Equity | -24.91M | -24.91M | -22.47M | -36.52M | -36.52M | -34.93M | -34.93M | -34.07M |
Total Investments | n/a | n/a | 31.88M | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MENS